1. Academic Validation
  2. Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors

Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors

  • Eur J Med Chem. 2023 Jul 5;255:115352. doi: 10.1016/j.ejmech.2023.115352.
Mariagrazia Rullo 1 Gabriella La Spada 1 Daniela Valeria Miniero 2 Andrea Gottinger 3 Marco Catto 1 Pietro Delre 4 Margherita Mastromarino 1 Tiziana Latronico 2 Sara Marchese 3 Giuseppe Felice Mangiatordi 4 Claudia Binda 3 Anna Linusson 5 Grazia Maria Liuzzi 2 Leonardo Pisani 6
Affiliations

Affiliations

  • 1 Dept. of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, via E. Orabona 4, 70125, Bari, Italy.
  • 2 Dept. of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via E. Orabona 4, 70125, Bari, Italy.
  • 3 Dept. of Biology and Biotechnology, University of Pavia, via Ferrata 9, 27100, Pavia, Italy.
  • 4 CNR, Institute of Crystallography, 70126, Bari, Italy.
  • 5 Department of Chemistry, Umeå University, 90187, Umeå, Sweden.
  • 6 Dept. of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, via E. Orabona 4, 70125, Bari, Italy. Electronic address: [email protected].
Abstract

Following a hybridization strategy, a series of 5-substituted-1H-indazoles were designed and evaluated in vitro as inhibitors of human Monoamine Oxidase (hMAO) A and B. Among structural modifications, the bioisostere-based introduction of 1,2,4-oxadiazole ring returned the most potent and selective human MAO B inhibitor (compound 20, IC50 = 52 nM, SI > 192). The most promising inhibitors were studied in cell-based neuroprotection models of SH-SY5Y and astrocytes line against H2O2. Moreover, preliminary drug-like features (aqueous solubility at pH 7.4; hydrolytic stability at acidic and neutral pH) were assessed for selected 1,2,4-oxadiazoles and compared to amide analogues through RP-HPLC methods. Molecular docking simulations highlighted the crucial role of molecular flexibility in providing a better shape complementarity for compound 20 within MAO B enzymatic cleft than rigid analogue 18. Enzymatic kinetics analysis along with thermal stability curves (Tm shift = +2.9 °C) provided clues of a tight-binding mechanism for hMAO B inhibition by 20.

Keywords

1,2,4-Oxadiazole; 1H-indazole; Bioisostere; Monoamine oxidases; Neuroprotection; Tight-binder.

Figures
Products